Orthopedic Specialities of NJ is categorized under Artificial Limbs in Hackensack, NJ .
Orthopedic Specialities of NJ was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Artificial Limbs business, which does work in the B2C market, and is classified as a Artificial Limbs, under code number 4461990 by the NAICS.
If you are seeking more information, feel free to contact June Vigilanti, Office Manager at the company’s single location by writing to 87 Summit Avenue, Hackensack, New Jersey NJ 07601 or by phoning (201) 489-0022. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Orthopedic Specialities of NJ |
| Contact Person: | June Vigilanti, Office Manager |
| Address: | 87 Summit Avenue, Hackensack, New Jersey 07601 |
| Phone Number: | (201) 489-0022 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Artificial Limbs |
| SIC Code: | 5999 |
| NAICS Code: | 4461990 |
| Share This Business: |
Orthopedic Specialities of NJ was started in 0 to provide professional Artificial Limbs under the SIC code 5999 and NAICS code 4461990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact June Vigilanti, Office Manager for inquiries that concern Orthopedic Specialities of NJ by calling the company number (201) 489-0022, as your correspondence is most welcome. Additionally, the physical location of the single location of Orthopedic Specialities of NJ can be found at the coordinates 40.887584,-74.058115 as well as the street address 87 Summit Avenue in Hackensack, New Jersey 07601.
For its online presence, you may visit Orthopedic Specialities of NJ’s website at and engage with its social media outlets through on Twitter and on Facebook.